We are live on ! Find out more
AI

Alphabet Inc Portfolio holdings

AUM $99.1B
1-Year Est. Return 124.46%
This Fund
S&P 500
This Quarter Est. Return
-14.79%
1 Year Est. Return
+124.46%
3 Year Est. Return
+326.82%
5 Year Est. Return
+231.24%
10 Year Est. Return
+1,201.66%
AUM
$4.14B
AUM Growth
-$73.7M
Cap. Flow
+$1.39B
Cap. Flow %
33.49%
Top 10 Hldgs %
76.41%
Holding
58
New
15
Increased
Reduced
10
Closed

Top Buys

Rank Stock Value
1
EQRX
EQRx, Inc. Common Stock
EQRX
+$449M
2
TOST icon
Toast
TOST
+$439M
3
IONQ icon
IonQ
IONQ
+$365M
4
PL icon
Planet Labs
PL
+$303M
5
FRSH icon
Freshworks
FRSH
+$146M

Top Sells

Rank Stock Value
1
PATH icon
UiPath
PATH
+$173M
2
HOOD icon
Robinhood
HOOD
+$85.2M
3
DUOL icon
Duolingo
DUOL
+$78.2M
4
RCUS icon
Arcus Biosciences
RCUS
+$59.6M
5
DXCM icon
DexCom
DXCM
+$58.4M

Sector Composition

Rank Sector Weight
1 Healthcare 47.22%
2 Technology 41.43%
3 Industrials 6.55%
4 Consumer Staples 2.6%
5 Financials 2.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PATH icon
1
UiPath
PATH
$9.4B
$607M 14.65%
14,068,674
-3,512,754
-20% -$173M
VERV
2
DELISTED
Verve Therapeutics
VERV
$405M 9.77%
10,974,011
DXCM icon
3
DexCom
DXCM
$34.3B
$378M 9.13%
2,816,044
-406,680
-13% -$58.4M
IONQ icon
4
IonQ
IONQ
$15.9B
$366M 8.83%
+21,907,038
New +$365M
TOST icon
5
Toast
TOST
$20.3B
$330M 7.96%
+9,496,884
New +$439M
EQRX
6
DELISTED
EQRx, Inc. Common Stock
EQRX
$324M 7.83%
+47,552,687
New +$449M
LYFT icon
7
Lyft
LYFT
$6.7B
$262M 6.33%
6,138,154
PL icon
8
Planet Labs
PL
$7.12B
$196M 4.74%
+31,942,641
New +$303M
OSCR icon
9
Oscar Health
OSCR
$9.4B
$189M 4.56%
24,042,864
BHIL
10
DELISTED
Benson Hill, Inc.
BHIL
$108M 2.6%
421,493
FRSH icon
11
Freshworks
FRSH
$3.62B
$106M 2.56%
+4,035,595
New +$146M
RCUS icon
12
Arcus Biosciences
RCUS
$3.72B
$104M 2.51%
2,563,441
-1,537,034
-37% -$59.6M
HOOD icon
13
Robinhood
HOOD
$93.7B
$87.5M 2.11%
4,928,535
-2,768,800
-36% -$85.2M
DM
14
DELISTED
Desktop Metal, Inc.
DM
$54.7M 1.32%
1,104,873
RLAY icon
15
Relay Therapeutics
RLAY
$4.11B
$48M 1.16%
1,564,173
-77,324
-5% -$2.44M
LYEL icon
16
Lyell Immunopharma
LYEL
$356M
$45.4M 1.1%
293,256
ME
17
DELISTED
23andMe Holding Co
ME
$44.9M 1.08%
+336,839
New +$62.2M
SANA icon
18
Sana Biotechnology
SANA
$1.18B
$43.5M 1.05%
2,812,500
IVVD icon
19
Invivyd
IVVD
$284M
$41.2M 1%
5,680,785
SNCE
20
DELISTED
Science 37 Holdings, Inc. Common Stock
SNCE
$40.4M 0.98%
+162,054
New +$36M
GLUE icon
21
Monte Rosa Therapeutics
GLUE
$1.14B
$29.9M 0.72%
1,464,015
BEAM icon
22
Beam Therapeutics
BEAM
$3.03B
$25.6M 0.62%
321,604
RAPT
23
DELISTED
RAPT Therapeutics
RAPT
$23.1M 0.56%
78,470
-10,311
-12% -$2.76M
ILMN icon
24
Illumina
ILMN
$32.6B
$20.3M 0.49%
54,967
ENJY
25
DELISTED
Enjoy Technology, Inc. Common Stock
ENJY
$20.1M 0.48%
+4,345,340
New +$32.3M

Similar funds

Alphabet Inc's Q4 2021 Portfolio in Review

As of Q4 2021, Alphabet Inc held 58 positions worth $4.14B, down 1.7% from $4.22B the previous quarter. Its ten largest holdings account for 76% of the portfolio.

Alphabet Inc deployed $1.39B of net new capital in Q4 2021, opening 15 new positions. Its largest new stake was EQRx, Inc. Common Stock: 47,552,687 shares worth $324M.

By sector, the portfolio is most concentrated in Healthcare at 47% of assets, down from 55% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was UiPath, an estimated $173M trimmed.

  • Alphabet Inc's largest Q4 2021 buy was EQRx, Inc. Common Stock: 47,552,687 shares worth $324M.
  • Alphabet Inc's biggest Q4 2021 reduction was UiPath, cutting an estimated $173M.
  • Alphabet Inc's ten largest holdings make up 76% of its $4.14B portfolio in Q4 2021.
  • Alphabet Inc opened 15 new positions and closed 0 in Q4 2021.
  • Alphabet Inc's portfolio value fell 1.7% quarter-over-quarter to $4.14B.

Based on Alphabet Inc's 13F filing for Q4 2021, filed 15 Nov 2022.